Indefinite Delivery Contract 75D30123D16646
Award Date
6/13/23
Last Date to Order
6/6/24
Federal Agency
CDC Pittsburgh
Awardee
Moderna US, Inc.
Ultimate Awardee
Modernatx, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Centers for Disease Control and Prevention (CDC) has awarded a multiple award indefinite delivery indefinite quantity (IDIQ) contract for the purchase of standard commercial COVID-19 vaccines with a pediatric indication. The maximum ordering quantity is 30 million doses, with a minimum order of 100 doses. The vaccines procured will support pediatric immunization programs through the Vaccines for Children (VFC) and Section 317 vaccine purchase programs. The IDIQ has a ceiling value of...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Moderna US, Inc. to provide adult COVID-19 vaccines. The contract has a ceiling value of $19,855,000 and a period of performance from June 1, 2025 to May 31, 2026. Moderna US, Inc. is a subsidiary of the parent company Modernatx, Inc., both of which are for-profit organizations specializing in the manufacture of pharmaceutical goods, including mRNA therapeutics and vaccines. Under...
The federal contract IDV award is for the procurement of COVID-19 mRNA vaccines from Moderna US, Inc., a subsidiary of Modernatx, Inc. The Centers for Disease Control and Prevention (CDC), a civilian agency, awarded this multiple award indefinite delivery contract with a ceiling value of $117,420,333 and a period of performance through September 30, 2025. The contract builds upon previous COVID-19 vaccine procurements by the Biomedical Advanced Research and Development Authority and the...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Moderna US, Inc. as the prime contractor. The contract has a ceiling value of $1,631,450.00 and a period of performance ending on June 30, 2026. The purpose of this contract is to procure adult vaccines, specifically COVID-19 mRNA vaccines, in support of the government's preparedness and response efforts. Moderna US, Inc. is a biotechnology company that develops and manufactures mRNA...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under a competitive solicitation to purchase standard adult vaccines. The contracts have a one year period of performance from July 1, 2022 to June 30, 2023 and a combined potential value of $85.6 million. Merck Sharp & Dohme LLC was awarded one of these contracts as the prime contractor. The contracts enable the CDC to order 12 types of adult vaccines for delivery within 15 business days....
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) awarded an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract to Bavarian Nordic, Inc. for the procurement of various adult vaccines. The $99,015,000 multiple-award contract has a period of performance from July 1, 2024 to June 30, 2025. The contract does not utilize any set-asides. The solicitation seeks the purchase of vaccines for Hepatitis A, Hepatitis B, Hepatitis...
This Indefinite Delivery Contract (IDC) award from the Centers for Disease Control and Prevention (CDC) is for the procurement of 12 standard adult vaccines to support state health department immunization programs. The $62,183,800 multiple-award contract has a period of performance from July 1, 2022 to June 30, 2023. The prime contractor is Pfizer Inc., a large pharmaceutical manufacturer that serves as a major federal supplier of medical products and vaccines. The contract requires the delivery...
The Centers for Disease Control and Prevention awarded multiple indefinite-delivery, indefinite-quantity contracts valued at up to $25,350,000 to supply adult vaccines for the period of July 1, 2023 through June 30, 2024. The prime contractor is VBI Vaccines (Delaware) Inc. The contracts aim to procure minimum and maximum quantities of 12 adult vaccines, including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, measles, mumps and rubella,...
The Centers for Disease Control and Prevention (CDC) awarded a $1,727,800 indefinite delivery contract to Grifols USA LLC, a global healthcare company, to purchase 12 standard adult vaccines. The contract has a one-year period of performance from July 1, 2022 to June 30, 2023 and is not designated with any set-aside provisions. The vaccines are required to have a minimum 12-month shelf life and be delivered within 15 business days of order. The vaccines will support CDC immunization awardees,...
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) awarded an indefinite-delivery, indefinite-quantity (IDIQ) contract to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of various adult vaccines. The contract has a potential value of $87,753,075 and a period of performance from July 1, 2023 through June 30, 2024. The vaccines will be delivered within 15 business days of order receipt and shipped FOB...